Balchem Corporation (NASDAQ:BCPC)
| Market Cap | 5.52B+10.5% |
| Revenue (ttm) | 1.09B+10.1% |
| Net Income | 164.41M+15.2% |
| EPS | 5.08+16.5% |
| Shares Out | 31.88M |
| PE Ratio | 33.83 |
| Forward PE | 30.77 |
| Dividend | $0.96(0.55%) |
| Ex-Dividend Date | Dec 31, 2026 |
| Volume | 491,675 |
| Open | 170.68 |
| Previous Close | 170.78 |
| Day's Range | 170.54 - 173.43 |
| 52-Week Range | 147.18 - 183.90 |
| Beta | 0.85 |
| Analysts | Buy |
| Price Target | 215.00(+24.11%) |
| Earnings Date | Oct 23, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About BCPC
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
$BCPC stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of BCPC by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Sep 17, 2026 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jul 10, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jul 10, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jul 9, 2026 |
| Josh GottheimerHouse / D | Sale$1.00K – $15.00K | Apr 9, 2025 |
| Josh GottheimerHouse / D | Sale$1.00K – $15.00K | Dec 2, 2021 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | May 21, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | May 21, 2020 |
Recently reported changes in BCPC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BCPC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BCPC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
BCPC Revenue by Segment or Geography
Source: SEC EDGAR (10-Q/10-K)
U.S. Patents
New BCPC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BCPC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in BCPC
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $168.86M |
| IWMiShares Russell 2000 ETF | $138.98M |
| VBVanguard Morningstar Small-Cap ETF | $118.27M |
| SDVYFirst Trust SMID Cap Rising Dividend Achievers ETF | $97.32M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $65.92M |
| VXFVanguard Extended Market ETF | $59.17M |
Estimated from each fund’s disclosed top holdings × AUM
BCPC Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from BCPC’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.
